Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: Lancet Oncol. 2022 Dec 6;24(1):77–90. doi: 10.1016/S1470-2045(22)00694-5

Figure 3: Forest plots of subgroup analyses.

Figure 3:

Figure 3:

(A) Invasive disease-free survival in the ITT prespecified subgroups. (B) Distant relapse-free survival in the ITT prespecified subgroups. ECOG PS=Eastern Cooperative Oncology Group performance status. ITT=intention to treat.

HHS Vulnerability Disclosure